FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 327:1204-1208 October 22, 1992 Number 17 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

BACKGROUND. Tolerance to the direct bronchodilator effects of beta 2-agonists does not appear to occur in asthma. However, it is not known whether this is true for the nonbronchodilator effects of these agents, which protect the airways against bronchoconstrictive stimuli. METHODS. We investigated whether tolerance develops to the protective effect of inhaled terbutaline on airway responsiveness to the bronchoconstrictors methacholine (which acts directly on airway smooth muscle) and AMP (which acts indirectly by stimulating the release of mediators from mast cells) during sustained treatment with terbutaline. In a randomized, double-blind, crossover study, 12 patients with mild asthma each inhaled a single dose of terbutaline (500 micrograms) or placebo before a challenge with a series of doubling doses of inhaled methacholine or AMP, before and after treatment for seven days with 500 micrograms of terbutaline four times daily or placebo. RESULTS. Before the seven days of treatment with terbutaline, a single dose of terbutaline reduced airway responsiveness to methacholine by 2.7 doubling doses (95 percent confidence interval, 1.9 to 3.5), but it had an even greater protective effect against AMP, reducing airway responsiveness by 3.8 doubling doses (95 percent confidence interval, 2.7 to 4.9; P less than 0.001). After seven days of treatment with terbutaline, the protective effect of terbutaline against methacholine decreased to 2.2 doubling doses (95 percent confidence interval, 1.3 to 3.0; P = 0.04), and that against AMP decreased even more, to 1.7 doubling doses (95 percent confidence interval, 1.1 to 2.4; P less than 0.001). By contrast, the bronchodilator response to terbutaline was unchanged during seven days of treatment with this agent. CONCLUSIONS. We observed tolerance to the nonbronchodilator actions of the inhaled beta 2-agonist terbutaline in patients with mild asthma, an effect that may be more pronounced in mast cells than in bronchial smooth muscle. This property of beta-agonists may constitute a drawback to their regular use in patients with asthma.

Source Information

Department of Thoracic Medicine, National Heart and Lung Institute, London, United Kingdom.

This article has been cited by other articles:

• Barnes, P. J. (2007). Scientific rationale for using a single inhaler for asthma control. Eur Respir J 29: 587-595 [Abstract] [Full Text]  
• Barnes, P. J. (2006). Treatment with (R)-Albuterol Has No Advantage over Racemic Albuterol.. Am. J. Respir. Crit. Care Med. 174: 969-972 [Full Text]  
• Giembycz, M. A., Newton, R. (2006). Beyond the dogma: novel {beta}2-adrenoceptor signalling in the airways.. Eur Respir J 27: 1286-1306 [Abstract] [Full Text]  
• Ek, A., Palmberg, L., Sundblad, B.-M., Larsson, K. (2005). Salmeterol Does Not Alter Increased Bronchial Responsiveness Caused by Organic Dust Exposure. Chest 128: 3038-3047 [Abstract] [Full Text]  
• Salpeter, S. R., Ormiston, T. M., Salpeter, E. E. (2004). Meta-Analysis: Respiratory Tolerance to Regular {beta}2-Agonist Use in Patients with Asthma. ANN INTERN MED 140: 802-813 [Abstract] [Full Text]  
• Gordon, J.R., Swystun, V.A., Li, F., Zhang, X., Davis, B.E., Hull, P., Cockcroft, D.W. (2003). Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response. Eur Respir J 22: 118-126 [Abstract] [Full Text]  
• Joos, G.F., O'Connor, B. (2003). Indirect airway challenges. Eur Respir J 21: 1050-1068 [Abstract] [Full Text]  
• Wraight, J.M., Hancox, R.J., Herbison, G.P., Cowan, J.O., Flannery, E.M., Taylor, D.R. (2003). Bronchodilator tolerance: the impact of increasing bronchoconstriction. Eur Respir J 21: 810-815 [Abstract] [Full Text]  
• Green, R H, Brightling, C E, Pavord, I D, Wardlaw, A J (2003). Management of asthma in adults: current therapy and future directions. Postgrad. Med. J. 79: 259-267 [Abstract] [Full Text]  
• Bernstein, I. L. (2002). {beta}2-Agonists: Deja vu All Over Again : The Second-Generation Controversy. Chest 122: 763-765 [Full Text]  
• Prieto, L., Gutierrez, V., Torres, V., Uixera, S., Marin, J. (2002). Effect of Salmeterol on Seasonal Changes in Airway Responsiveness and Exhaled Nitric Oxide in Pollen-Sensitive Asthmatic Subjects*. Chest 122: 798-805 [Abstract] [Full Text]  
• Ketchell, R.I., Jensen, M.W., Spina, D., O'Connor, B.J. (2002). Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine. Eur Respir J 19: 611-616 [Abstract] [Full Text]  
• Barnes, P.J. (2002). Scientific rationale for inhaled combination therapy with long-acting {beta}2-agonists and corticosteroids. Eur Respir J 19: 182-191 [Abstract] [Full Text]  
• Cates, C. (2001). Extracts from ""Clinical Evidence"": Chronic asthma. BMJ 323: 976-979 [Full Text]  
• Giannini, D., Di Franco, A., Bacci, E., Dente, F. L., Bartoli, M. L., Vagaggini, B., Paggiaro, P. (2001). Tolerance to the Protective Effect of Salmeterol on Allergen Challenge Can Be Partially Restored by the Withdrawal of Salmeterol Regular Treatment. Chest 119: 1671-1675 [Abstract] [Full Text]  
• Holgate, S. T. (2001). Therapeutic Options for Persistent Asthma. JAMA 285: 2637-2639 [Full Text]  
• Sears, M. R. (2001). Deleterious Effects of Inhaled {beta}-Agonists : Short-Acting and Long-Acting Agents Differ. Chest 119: 1297-1299 [Full Text]  
• Cloosterman, S. G. M., Bijl-Hofland, I. D., van Herwaarden, C. L. A., Akkermans, R. P., van den Elshout, F. J. J., Folgering, H. T. M., van Schayck, C. P. (2001). A Placebo-Controlled Clinical Trial of Regular Monotherapy With Short-Acting and Long-Acting {beta}2-Agonists in Allergic Asthmatic Patients. Chest 119: 1306-1315 [Abstract] [Full Text]  
• D'Urzo, A. D., Chapman, K. R., Cartier, A., Hargreave, F. E., Fitzgerald, M., Tesarowski, D. (2001). Effectiveness and Safety of Salmeterol in Nonspecialist Practice Settings. Chest 119: 714-719 [Abstract] [Full Text]  
• Jokic, R., Swystun, V. A., Davis, B. E., Cockcroft, D. W. (2001). Regular Inhaled Salbutamol : Effect on Airway Responsiveness to Methacholine and Adenosine 5'-Monophosphate and Tolerance to Bronchoprotection. Chest 119: 370-375 [Abstract] [Full Text]  
• Giannini, D., Di Franco, A., Bacci, E., Dente, F. L., Taccola, M., Vagaggini, B., Paggiaro, P. (2000). The Protective Effect of Salbutamol Inhaled Using Different Devices on Methacholine Bronchoconstriction. Chest 117: 1319-1323 [Abstract] [Full Text]  
• ALDRIDGE, R. E., HANCOX, R. J., ROBIN TAYLOR, D., COWAN, J. O., WINN, M. C., FRAMPTON, C. M., IAN TOWN, G. (2000). Effects of Terbutaline and Budesonide on Sputum Cells and Bronchial Hyperresponsiveness In Asthma. Am. J. Respir. Crit. Care Med. 161: 1459-1464 [Abstract] [Full Text]  
• Mak, J. C. W., Roffel, A. F., Katsunuma, T., Elzinga, C. R. S., Zaagsma, J., Barnes, P. J. (2000). Up-Regulation of Airway Smooth Muscle Histamine H1 Receptor mRNA, Protein, and Function by beta 2-Adrenoceptor Activation. Mol. Pharmacol. 57: 857-864 [Abstract] [Full Text]  
• Billington, C. K., Hall, I. P., Mundell, S. J., Parent, J.-L., Panettieri, R. A. Jr., Benovic, J. L., Penn, R. B. (1999). Inflammatory and Contractile Agents Sensitize Specific Adenylyl Cyclase Isoforms in Human Airway Smooth Muscle. Am. J. Respir. Cell Mol. Bio. 21: 597-606 [Abstract] [Full Text]  
• Charron, P. D., Fawley, J. P., Maron, M. B. (1999). Effect of epinephrine on alveolar liquid clearance in the rat. J. Appl. Physiol. 87: 611-618 [Abstract] [Full Text]  
• NIGHTINGALE, J. A., ROGERS, D. F., BARNES, P. J. (1999). Differential Effect of Formoterol on Adenosine Monophosphate and Histamine Reactivity in Asthma. Am. J. Respir. Crit. Care Med. 159: 1786-1790 [Abstract] [Full Text]  
• WALLIN, A., SANDSTRÖM, T., SÖDERBERG, M., HOWARTH, P., LUNDBÄCK, B., DELLA-CIOPPA, G., WILSON, S., JUDD, M., HOLGATE, S., LINDBERG, A., LARSSEN, L., Judd, M., Melander, B. (1999). The Effects of Regular Inhaled Formoterol, Budesonide, and Placebo on Mucosal Inflammation and Clinical Indices in Mild Asthma. Am. J. Respir. Crit. Care Med. 159: 79-86 [Abstract] [Full Text]  
• BARNES, P. J. (1998). Pharmacology of Airway Smooth Muscle. Am. J. Respir. Crit. Care Med. 158: S123-S132 [Abstract] [Full Text]  
• JOHNSON, M. (1998). The beta -Adrenoceptor. Am. J. Respir. Crit. Care Med. 158: S146-S153 [Abstract] [Full Text]  
• CHEUNG, D., WEVER, A. M. J., de GOEIJ, J. A., de GRAAFF, C. S., STEEN, H., STERK, P. J. (1998). Effects of Theophylline on Tolerance to the Bronchoprotective Actions of Salmeterol in Asthmatics In Vivo. Am. J. Respir. Crit. Care Med. 158: 792-796 [Abstract] [Full Text]  
• Nelson, J. A., Strauss, L., Skowronski, M., Ciufo, R., Novak, R., McFadden, E.R. (1998). Effect of Long-Term Salmeterol Treatment on Exercise-Induced Asthma. NEJM 339: 141-146 [Abstract] [Full Text]  
• Taylor, D., Jensen, M., Aikman, S., Harris, J., Barnes, P., O'Connor, B. (1997). Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma. Am. J. Respir. Crit. Care Med. 156: 1731-1737 [Abstract] [Full Text]  
• Gauvreau, G., Jordana, M, Watson, R., Cockroft, D., O'Byrne, P. (1997). Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. Am. J. Respir. Crit. Care Med. 156: 1738-1745 [Abstract] [Full Text]  
• Pauwels, R. A., Lofdahl, C.-G., Postma, D. S., Tattersfield, A. E., O'Byrne, P., Barnes, P. J., Ullman, A., The Formoterol and Corticosteroids Establishing Th, (1997). Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma. NEJM 337: 1405-1411 [Abstract] [Full Text]  
• INOUE, H., AIZAWA, H., MATSUMOTO, K., SHIGYO, M., TAKATA, S., HARA, M., HARA, N. (1997). Effect of beta 2-agonists on Histamine-induced Airway Microvascular Leakage in Ozone-exposed Guinea Pigs. Am. J. Respir. Crit. Care Med. 156: 723-727 [Abstract] [Full Text]  
• YATES, D. H., WORSDELL, M., BARNES, P. J. (1997). Effect of Regular Salmeterol Treatment on Albuterol-induced Bronchoprotection in Mild Asthma. Am. J. Respir. Crit. Care Med. 156: 988-991 [Abstract] [Full Text]  
• Wilding, P., Clark, M., Coon, J. T., Lewis, S., Rushton, L., Bennett, J., Oborne, J., Cooper, S., Tattersfield, A. E (1997). Effect of long term treatment with salmeterol on asthma control: a double blind, randomised crossover study. BMJ 314: 1441-1441 [Abstract] [Full Text]  
• McGraw, D. W., Liggett, S. B. (1997). Heterogeneity in beta -Adrenergic Receptor Kinase Expression in the Lung Accounts for Cell-specific Desensitization of the beta 2-Adrenergic Receptor. J. Biol. Chem. 272: 7338-7344 [Abstract] [Full Text]  
• Nelson, H. S. (1995). {beta}-Adrenergic Bronchodilators. NEJM 333: 499-507 [Full Text]  
• Weinberger, S. E. (1993). Recent Advances in Pulmonary Medicine- First of Two Parts. NEJM 328: 1389-1397 [Full Text]  
• Hoshiko, K., Chapman, I.D., Morley, J., Cheung, D., Sterk, P.J., O'Connor, B. J., Barnes, P. J. (1993). Sympathomimetic Agents and Airway Hyperreactivity. NEJM 328: 665-666 [Full Text]  
• (1992). TOLERANCE TO BETA-AGONISTS ERODES THEIR BENEFIT IN ASTHMA. JWatch General 1992: 5-5 [Full Text]